An Act To Promote the Proper Disposal of Used Medical Sharps
Sec. 1. 38 MRSA §1319-O, sub-§3, ¶F is enacted to read:
Sec. 2. 38 MRSA §1611 is enacted to read:
§ 1611. Medical sharps
(1) Has a physical presence in the United States and causes a medical sharp to be manufactured or has legal ownership of the brand, brand name or cobrand under which a medical sharp is sold;
(2) Imports a medical sharp branded or manufactured by a person or entity that has no physical presence in the United States; or
(3) Sells at wholesale a medical sharp and does not have legal ownership of the brand or brand name, but elects to fulfill the manufacturer's responsibilities for that medical sharp.
"Manufacturer" does not include a compounding pharmacy or pharmacist who compounds a prescribed drug for an individual and uses a medical sharp as a delivery system or a retailer that puts its store label on a medical sharp unless the retailer imports the medical sharp directly from a person that has no physical presence in the United States.
(1) A fee of $1,000 for each manufacturer represented in a program plan and report; or
(2) A fee of $10,000 for a program plan and report submitted on behalf of 10 or more manufacturers.
Processing fees collected by the department pursuant to this paragraph must be deposited in the Maine Environmental Protection Fund established in section 351.
(1) Promote the use of the program and the proper disposal of unwanted medical sharps so that collection options are widely understood by consumers, pharmacists, retailers of medical sharps and health care practitioners, including doctors and other prescribers; and
(2) Provide a toll-free telephone number and publicly accessible website where information regarding collection options and locations is made available; and
(1) A list of manufacturers participating in the program and their contact information;
(2) A list of the biomedical waste disposal or treatment facilities used, the location of those facilities and the weight of unwanted medical sharps treated at each facility;
(3) Documentation verifying collection and disposal of the unwanted medical sharps;
(4) A statement of whether policies and procedures for transporting and disposing of unwanted medical sharps, as established in the program plan, were followed and a description of noncompliance with those policies and procedures, if any;
(5) A statement of whether any safety or security problems occurred during collection, handling, transportation, treatment or disposal of unwanted medical sharps and, if so, what changes are proposed for policies, procedures or tracking mechanisms to improve safety and security in the future;
(6) A description of the public education effort and communications strategy required under subsection 4, paragraph E;
(7) A list of active sharps collection centers and locations; and
(8) Any other information that the department or the Department of Health and Human Services may reasonably require.
summary
This bill requires a manufacturer of medical sharps to participate in a program, individually or in conjunction with other manufacturers, for the collection, handling, transportation, treatment and disposal of unwanted medical sharps. It also provides that an entity that uses medical sharps is not required to dispose of them by shredding.